Immune System: A complex network of cells, tissues, and organs that defend the body against pathogens by recognizing and eliminating foreign invaders while distinguishing them from self-cells.
Pathogen: A microorganism such as bacteria, viruses, fungi, or parasites that causes disease.
Antigen: A substance, often a protein or polysaccharide, that triggers an immune response by being recognized as foreign by immune cells.
Innate Immunity: The body's immediate, non-specific defense mechanism that responds rapidly to pathogens using physical barriers, chemical defenses, and immune cells like macrophages and natural killer cells.
Adaptive Immunity: A specific immune response involving lymphocytes (B and T cells) that develops over time, has memory, and provides long-lasting protection against particular pathogens.
Lymphatic System: A network of vessels, lymph nodes, and organs that transports lymph fluid, filters pathogens, and facilitates immune cell activation.
The immune system distinguishes between self and non-self to prevent attacking the body's own tissues, preventing autoimmune diseases.
Innate immunity provides the first line of defense, characterized by rapid response but limited specificity.
Adaptive immunity involves lymphocytes that recognize specific antigens, leading to targeted responses and immunological memory.
The lymphatic system supports immune surveillance by transporting immune cells and filtering pathogens through lymph nodes.
Effective immune responses depend on the coordination between innate and adaptive components, including processes like antigen presentation and antibody production.
Disruptions in immune function can lead to autoimmune diseases, immunodeficiency, or hypersensitivity reactions such as allergies.
The immune system is an intricate defense network that combines rapid, non-specific responses with highly specific, memory-based mechanisms to protect the body from disease, with the lymphatic system playing a vital role in immune surveillance and fluid regulation.
Innate Immunity: The body's immediate, non-specific defense mechanism against pathogens, present from birth, providing rapid response without prior exposure.
Physical Barriers: Structural defenses such as skin and mucous membranes that prevent pathogen entry into the body.
Chemical Barriers: Substances like antimicrobial peptides, enzymes (e.g., lysozyme), and acidic environments (e.g., stomach acid) that inhibit or destroy pathogens.
Phagocytes: Immune cells (e.g., macrophages, neutrophils) that engulf and digest pathogens through phagocytosis, initiating the immune response.
Natural Killer (NK) Cells: Lymphocytes that identify and destroy infected or abnormal cells (e.g., tumor cells) without prior sensitization.
Complement System: A group of plasma proteins that enhance (complement) the ability of antibodies and phagocytes to clear microbes and damaged cells, promoting inflammation and cell lysis.
Innate immunity acts as the first line of defense, providing rapid, generalized protection against pathogens.
Physical and chemical barriers are nonspecific but crucial in preventing pathogen entry; their effectiveness is the body's initial filter.
Phagocytes recognize pathogen-associated molecular patterns (PAMPs) via pattern recognition receptors (PRRs), enabling quick identification of invaders.
NK cells detect cells lacking MHC I molecules or displaying stress signals, leading to targeted destruction.
The complement system can be activated via three pathways (classical, lectin, alternative), culminating in pathogen lysis, opsonization, and inflammation.
Innate immunity does not confer long-lasting immunity; it provides immediate but temporary defense.
These components work synergistically to contain infections until adaptive immunity is activated.
Innate immunity provides the body's rapid, nonspecific initial defense through physical barriers, immune cells like phagocytes and NK cells, and the complement system, forming the essential first step in immune protection.
Adaptive Immunity: A specific immune response that develops after exposure to a pathogen, characterized by memory and the ability to target particular antigens.
B Cells: Lymphocytes that mature in the bone marrow; responsible for humoral immunity by producing antibodies against specific antigens.
T Cells: Lymphocytes that mature in the thymus; involved in cell-mediated immunity, including helper functions (CD4+) and cytotoxic functions (CD8+).
Antigen: A molecule or molecular structure recognized by the immune system as foreign, triggering an immune response.
Memory Cells: Long-lived B or T lymphocytes that provide rapid and robust responses upon re-exposure to their specific antigen.
Major Histocompatibility Complex (MHC): Cell surface molecules that present processed antigen fragments to T cells, essential for antigen recognition.
Adaptive immunity is highly specific, involving lymphocytes (B and T cells) that recognize unique antigens via their receptors.
B cells produce antibodies that neutralize pathogens, facilitate phagocytosis, and activate the complement system.
T cells recognize antigens presented on MHC molecules; helper T cells (CD4+) activate other immune cells, while cytotoxic T cells (CD8+) kill infected cells.
The development of memory cells ensures faster and more effective responses upon subsequent exposures, forming the basis for immunological memory and vaccination.
Clonal selection: upon encountering their specific antigen, lymphocytes proliferate to produce a clone of cells tailored to that antigen.
Adaptive immunity provides a targeted and long-lasting defense against pathogens through specialized lymphocytes and immunological memory, forming the foundation for effective vaccines and immune therapies.
The lymphatic system is essential for fluid regulation, fat absorption, and immune surveillance, serving as a crucial component of the body's defense and homeostasis mechanisms.
Antigen-Presenting Cells (APCs): Specialized immune cells (e.g., dendritic cells, macrophages, B cells) that process and display antigens on their surface via MHC molecules to activate T cells.
Major Histocompatibility Complex (MHC): A set of cell surface molecules essential for antigen presentation; divided into:
Endogenous Antigens: Internal cell-derived proteins, typically from viruses or abnormal cells, presented on MHC I molecules.
Exogenous Antigens: External pathogens or particles taken up by APCs, presented on MHC II molecules.
T Cell Activation: The process by which T cells recognize antigen-MHC complexes via their T cell receptors (TCRs), leading to immune response initiation.
Cross-Presentation: A process where certain APCs present extracellular antigens on MHC I molecules, enabling cytotoxic T cell activation against pathogens that do not infect APCs directly.
Antigen presentation via MHC molecules by specialized cells is essential for the activation of T lymphocytes, orchestrating a targeted and effective immune response against pathogens and abnormal cells.
Humoral Immunity: A branch of adaptive immunity mediated by B lymphocytes that produce antibodies to neutralize extracellular pathogens and toxins.
B Cells (B Lymphocytes): White blood cells that recognize specific antigens via their B cell receptors (BCRs) and differentiate into plasma cells to produce antibodies.
Antibodies (Immunoglobulins): Y-shaped glycoproteins produced by plasma cells that specifically bind to antigens, facilitating pathogen neutralization and clearance.
Plasma Cells: Differentiated B cells that secrete large quantities of antibodies specific to an encountered antigen.
Antigen-Antibody Complex: The binding of an antibody to its specific antigen, leading to pathogen neutralization, opsonization, or activation of the complement system.
Class Switching: The process by which a B cell changes the antibody isotype (e.g., from IgM to IgG, IgA, or IgE) to adapt the immune response to different pathogens or tissues.
Activation of B Cells: B cells are activated when their BCR binds to a specific antigen; helper T cells (Th cells) provide additional signals (via cytokines and CD40-CD40L interaction) to fully activate B cells.
Clonal Expansion & Differentiation: Once activated, B cells proliferate (clonal expansion) and differentiate into plasma cells that produce large amounts of antibodies, or memory B cells for long-term immunity.
Antibody Functions:
Class Switching & Affinity Maturation:
Memory & Secondary Response: Memory B cells persist after infection, enabling a faster and more robust antibody response upon re-exposure to the same antigen.
Humoral immunity relies on B cells and the production of specific antibodies that neutralize pathogens, facilitate their clearance, and provide long-lasting immune memory, forming a critical component of adaptive defense.
Cell-Mediated Immunity (CMI): An immune response primarily involving T lymphocytes that targets infected, cancerous, or foreign cells directly, without the involvement of antibodies.
T Lymphocytes (T Cells): White blood cells originating from the thymus that are central to CMI; include helper T cells (CD4+) and cytotoxic T cells (CD8+).
Helper T Cells (CD4+): T cells that assist other immune cells by releasing cytokines, activating macrophages, B cells, and cytotoxic T cells.
Cytotoxic T Cells (CD8+): T cells that directly kill infected or abnormal cells by inducing apoptosis through the release of perforins and granzymes.
Major Histocompatibility Complex (MHC) Class I & II: Molecules on cell surfaces that present processed antigen fragments to T cells; MHC I presents to CD8+ T cells, MHC II to CD4+ T cells.
Cytokines: Signaling proteins released by T cells and other immune cells that coordinate and amplify the immune response, e.g., interleukins and interferons.
Activation of T Cells: T cells are activated when their T cell receptor (TCR) recognizes a specific antigen presented on MHC molecules by APCs (antigen-presenting cells).
Role of MHC in CMI: MHC I molecules present endogenous antigens (from within infected cells) to CD8+ cytotoxic T cells, enabling targeted killing. MHC II molecules present exogenous antigens to CD4+ helper T cells, which then activate other immune components.
Killing Mechanism: Cytotoxic T cells induce apoptosis in infected cells via perforin (creates pores) and granzymes (trigger apoptosis). They can also release cytokines like IFN-γ to activate macrophages.
Memory Formation: After an infection, memory cytotoxic T cells persist, providing faster and more robust responses upon re-exposure.
Importance in Viral Infections & Tumor Surveillance: CMI is crucial for controlling viral infections and eliminating tumor cells that express abnormal antigens.
Regulation: T cell responses are tightly regulated to prevent excessive tissue damage, involving co-stimulatory signals and regulatory T cells.
Cell-mediated immunity, primarily orchestrated by T lymphocytes, is essential for directly targeting and destroying infected or abnormal cells, playing a vital role in viral defense, tumor suppression, and immune regulation.
Autoimmune Disease: A condition where the immune system mistakenly attacks the body's own tissues, recognizing self-antigens as foreign. Examples include rheumatoid arthritis and type 1 diabetes.
Immunodeficiency Disorder: A disorder characterized by an impaired immune response, leading to increased susceptibility to infections. Can be primary (genetic) or secondary (acquired), such as HIV/AIDS.
Allergy: An exaggerated immune response to harmless environmental substances (allergens), often involving IgE antibodies and mast cell activation, resulting in symptoms like sneezing or anaphylaxis.
Hypersensitivity: An excessive or misdirected immune response causing tissue damage. Types include immediate (Type I), antibody-mediated (Type II), immune complex (Type III), and cell-mediated (Type IV).
Tolerance: The immune system's ability to recognize self-antigens and avoid attacking the body's own tissues; failure leads to autoimmune diseases.
Immune disorders encompass a spectrum of conditions where the immune system either attacks the body’s own tissues, fails to defend effectively, or overreacts to harmless substances, requiring targeted diagnostic and therapeutic approaches.
Vaccination strategies utilize various types of vaccines to safely stimulate the immune system, aiming for long-lasting protection and herd immunity, which are essential for controlling and eradicating infectious diseases worldwide.
Microbiome: The collection of all microorganisms (bacteria, fungi, viruses, and protozoa) living symbiotically within and on the human body, especially in the gut, skin, and mucous membranes.
Dysbiosis: An imbalance or harmful alteration in the microbiome composition that can negatively affect health, leading to increased susceptibility to disease.
Immune Modulation: The process by which the microbiome influences the development, regulation, and response of the immune system, promoting immune tolerance or activation.
Gut-Associated Lymphoid Tissue (GALT): A component of the mucosal immune system in the gut that interacts with microbiota to regulate immune responses.
Short-Chain Fatty Acids (SCFAs): Metabolic byproducts produced by gut bacteria through fermentation of dietary fibers, which play a role in maintaining immune homeostasis.
Pattern Recognition Receptors (PRRs): Receptors on immune cells that detect microbial-associated molecular patterns (MAMPs), facilitating immune responses to microbiota.
The microbiome is essential for the development and education of the immune system, especially in early life, influencing immune tolerance and defense mechanisms.
A diverse microbiome supports immune homeostasis, while dysbiosis is linked to autoimmune diseases, allergies, inflammatory bowel disease, and metabolic disorders.
Microbial metabolites like SCFAs help regulate immune responses by promoting regulatory T cell development and reducing inflammation.
The microbiome interacts with immune cells via pattern recognition receptors (PRRs), shaping immune responses to pathogens and preventing overreactions to harmless antigens.
Antibiotic use, diet, and lifestyle significantly influence microbiome composition, impacting immune health.
Maintaining microbiome diversity through diet, probiotics, and avoiding unnecessary antibiotics can support optimal immune function.
The microbiome plays a crucial role in shaping and regulating the immune system; a balanced and diverse microbiota promotes immune tolerance and protection, while imbalance (dysbiosis) can contribute to immune-related diseases.
Immunotherapy: A treatment that utilizes or enhances the body's immune system to fight diseases, particularly cancer and infections. It includes approaches like monoclonal antibodies, checkpoint inhibitors, and cell therapies.
Checkpoint Inhibitors: Drugs that block immune checkpoint proteins (e.g., PD-1, CTLA-4), which tumors exploit to evade immune detection. Their inhibition reactivates T cells to attack cancer cells.
CAR T-cell Therapy: A form of adoptive cell transfer where a patient's T cells are genetically modified to express chimeric antigen receptors (CARs) that target specific tumor antigens, then reinfused to destroy cancer cells.
Monoclonal Antibodies (mAbs): Laboratory-produced molecules engineered to bind specific antigens on pathogens or cancer cells, facilitating immune-mediated destruction or blocking growth signals.
Tumor Microenvironment (TME): The environment surrounding a tumor, including immune cells, blood vessels, and signaling molecules, which can influence the effectiveness of immunotherapy.
Neoantigens: Novel antigens formed due to tumor-specific mutations, recognized as foreign by the immune system, making them prime targets for personalized immunotherapy.
Advances in immunotherapy have revolutionized cancer treatment, offering durable responses where traditional therapies may fail.
Checkpoint inhibitors (e.g., pembrolizumab, nivolumab) have shown significant success in treating melanoma, lung, and other cancers by unleashing T cell activity.
CAR T-cell therapy has been particularly effective against certain hematologic malignancies like B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma.
The tumor microenvironment often suppresses immune responses; strategies to modify or overcome this suppression are key to improving immunotherapy outcomes.
Biomarkers such as PD-L1 expression and tumor mutational burden guide patient selection and predict responses to immunotherapy.
Challenges include immune-related adverse events (autoimmune-like side effects), resistance mechanisms, and high costs.
Immunotherapy harnesses and enhances the immune system's ability to target diseases, especially cancer, with recent advances like checkpoint inhibitors and CAR T-cell therapy offering promising, durable treatment options, though challenges remain in optimizing efficacy and managing side effects.
| Aspect | Innate Immunity | Adaptive Immunity |
|---|---|---|
| Response Time | Immediate (seconds to hours) | Delayed (days) |
| Specificity | Non-specific, recognizes PAMPs | Highly specific, recognizes unique antigens |
| Memory | No memory | Memory cells provide long-lasting immunity |
| Key Cells | Macrophages, neutrophils, NK cells, complement | B cells, T cells |
| Activation Pathways | Physical barriers, phagocytosis, complement | Clonal selection, antigen presentation |
| Response Duration | Short-term, rapid | Long-term, sustained |
| Aspect | Lymphatic System Functions | Key Components |
|---|---|---|
| Fluid Regulation | Returns interstitial fluid to blood | Lymph vessels, lymph nodes |
| Immune Surveillance | Filters pathogens, activates immune cells | Lymph nodes, spleen, thymus |
| Fat Absorption | Transports dietary fats via lacteals | Lacteals in small intestine |
| Blood Filtration | Spleen filters blood for pathogens and old cells | Spleen, lymph nodes |
Testez vos connaissances sur Fundamentals of the Immune System avec 9 questions à choix multiples avec corrections détaillées.
1. What is the lymphatic system?
2. What is the primary role of antigen in the immune system?
Mémorisez les concepts clés de Fundamentals of the Immune System avec 10 flashcards interactives.
Immune System — definition?
Network defending against pathogens.
Immune System — function?
Defends body using innate and adaptive responses.
Innate Immunity — components?
Physical barriers, phagocytes, NK cells, complement.
Importe ton cours et l'IA génère fiches, QCM et flashcards en 30 secondes.
Générateur de fiches